Challenges in the Management of Long-Therm Corticotherapy Treatment at Smoker Pacient with Severe Asthma

1 Selroos, Olof, et al. National and Regional Asthma “ Programmes in Europe.” European Respiratory Review, vol. 24, no. 137, 31 Aug. 2015, pp. 474–483, https://doi.org/10.1183/16000617.00008114. Search in Google Scholar

2 Wang, Eileen, et al. Characterization of Severe “ Asthma Worldwide.” Chest, vol. 157, no. 4, Apr. 2020, pp. 790–804, https://doi.org/10.1016/j.chest.2019.10.053. Search in Google Scholar

3 Thomson, N.C. Asthma and Cigarette Smoking.” “European Respiratory Journal, vol. 24, no. 5, 1 Nov. 2004, pp. 822–833, erj.ersjournals.com/content/24/5/822, https://doi.org/10.1183/09031936.04.00039004. Search in Google Scholar

4 Tiotiu, Angelica, et al. The Impact of Tobacco “Smoking on Adult Asthma Outcomes.” International Journal of Environmental Research and Public Health, vol. 18, no. 3, 23 Jan. 2021, p. 992, www.ncbi.nlm.nih.gov/pmc/articles/PMC7908240/, https://doi.org/10.3390/ijerph18030992. Search in Google Scholar

5 Bachelez, Hervé, et al. Generalized Pustular “Psoriasis Is a Disease Distinct from Psoriasis Vulgaris: Evidence and Expert Opinion.” Expert Review of Clinical Immunology, vol. 18, no. 10, 1 Oct. 2022, pp. 1033–1047, pubmed.ncbi.nlm.nih.gov/36062811/, https://doi.org/10.1080/1744666X.2022.2116003. Accessed 12 July 2023. Search in Google Scholar

6 Mao, Bei, et al. Asthma and Bronchiectasis “Exacerbation.” European Respiratory Journal, vol. 47, no. 6, 1 June 2016, pp. 1680–1686, erj.ersjournals.com/content/47/6/1680, https://doi.org/10.1183/13993003.01862-2015. Search in Google Scholar

7 Yang, Bumhee, et al. Association between Smoking “Status and Incident Non-Cystic Fibrosis Bronchiectasis in Young Adults: A Nationwide Population-Based Study.” Journal of Personalized Medicine, vol. 12, no. 5, 26 Apr. 2022, p. 691, https://doi.org/10.3390/jpm12050691. Search in Google Scholar

8 Mahler, Beatrice. “Assessing the Quality of Life with CAT in Bronchiectasis Patients.” European Respiratory Journal, vol. 38, no. Suppl 55, 1 Sept. 2011, erj.ersjournals.com/content/38/Suppl_55/p943. Accessed 12 July 2023. Search in Google Scholar

9 Guy G. Brusselle, M.D., Ph.D., and Gerard H. Koppelman, Biologic Therapies for Severe Asthma, N Engl J Med 2022;386:157-71.DOI: 10.1056/NEJMra 2032506 Open DOISearch in Google Scholar

10 Tiotiu, Angelica, et al. Does Asthma-Bronchiectasis “ Overlap Syndrome (ABOS) Really Exist?” Journal of Asthma, 18 Apr. 2023, pp. 1–11, https://doi.org/10.1080/02770903.2023.2203743. Accessed 22 Apr. 2023. Search in Google Scholar

11 Perez-Miranda, Javier, et al. Bronchiectasis in “Severe Asthma.” Current Opinion in Pulmonary Medicine, vol. 25, no. 1, Jan. 2019, pp. 71–78, https://doi.org/10.1097/mcp.0000000000000542. Accessed 31 Oct. 2022. Search in Google Scholar

12 Damiani, Giovanni, et al. The Global, Regional, and “National Burden of Psoriasis: Results and Insights from the Global Burden of Disease 2019 Study.” Frontiers in Medicine, vol. 8, 16 Dec. 2021, https://doi.org/10.3389/fmed.2021.743180. Search in Google Scholar

13 Wang, Jian, et al. “Association between Psoriasis and Asthma Risk: A Meta-Analysis.” Allergy and Asthma Proceedings, vol. 39, no. 2, 1 Mar. 2018, pp. 103–109, https://doi.org/10.2500/aap.2018.39.4109. Accessed 12 Dec. 2020. Search in Google Scholar

14 Busse, William W. Asthma and Psoriasis: What Do “They Have in Common? IL-17A!” Journal of Allergy and Clinical Immunology, vol. 144, no. 5, Nov. 2019, pp. 1169–1171, https://doi.org/10.1016/j.jaci.2019.09.006. Accessed 6 June 2020. Search in Google Scholar

15 Zazzali, James L., et al. Risk of Corticosteroid-“Related Adverse Events in Asthma Patients with High Oral Corticosteroid Use.” Allergy and Asthma Proceedings, vol. 36, no. 4, 1 July 2015, pp. 268–274, https://doi.org/10.2500/aap.2015.36.3863. Accessed 30 Jan. 2020. Search in Google Scholar

16 Orsi, Fernanda A., et al. Glucocorticoid Use and Risk “ of First and Recurrent Venous Thromboembolism: Self-Controlled Case-Series and Cohort Study.” British Journal of Haematology, vol. 193, no. 6, 21 Mar. 2021, pp. 1194–1202, https://doi.org/10.1111/bjh.17388. Accessed 8 July 2022. Search in Google Scholar

17 Heinrich, Matthew, et al. Erythrodermic Psoriasis “Secondary to Systemic Corticosteroids.” Baylor University Medical Center Proceedings, vol. 33, no. 1, 11 Nov. 2019, pp. 113–114, https://doi.org/10.1080/08998280.2019.1686911. Accessed 6 Dec. 2021. Search in Google Scholar

18 Liao, Wilson, et al. Erythrodermic Psoriasis: “ Pathophysiology and Current Treatment Perspectives.” Psoriasis: Targets and Therapy, vol. Volume 6, July 2016, pp. 93–104, https://doi.org/10.2147/ptt.s101232. Search in Google Scholar